The list of on- and off-label indications for anticonvulsants topiramate and zonisamide is ever growing and, with that, use of the drugs has been on the rise.

Sonya Collins

Ten years after their last recommendations for neuropathic pain treatment, a special interest group conducted an analysis that’s findings support modest revisions to recommended treatments.

Kevin Willmann

A health system in Pennsylvania found that integrating clinical pharmacist resources systemwide improved clinical, operational, and financial outcomes.

Lauren Howell, PharmD

Use of weight loss medications is on the rise among adolescents with obesity, but the number of prescriptions account for very few of the U.S. adolescents for whom the drugs are indicated, according to CDC’s June 5 Morbidity and Mortality Weekly Report.

Sonya Collins

A recent study finds that buprenorphine prescribing from pharmacists remains low and variations in state laws may still restrict pharmacist prescribing even after the implementation of the Mainstreaming Addiction Treatment (MAT) Act in December 2022.

Loren Bonner